OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 90 filers reported holding OLEMA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,628,249 | +30.9% | 131,842 | -4.3% | 0.00% | +33.3% |
| Q2 2023 | $1,243,467 | +122.0% | 137,704 | -14.7% | 0.00% | +50.0% |
| Q1 2023 | $560,173 | +24.1% | 161,433 | -12.4% | 0.00% | +100.0% |
| Q4 2022 | $451,466 | -44.0% | 184,272 | -36.9% | 0.00% | -66.7% |
| Q3 2022 | $806,000 | -37.6% | 291,970 | -7.9% | 0.00% | -25.0% |
| Q2 2022 | $1,291,000 | -49.0% | 317,156 | -46.6% | 0.00% | -42.9% |
| Q1 2022 | $2,532,000 | -56.7% | 594,343 | -4.8% | 0.01% | -41.7% |
| Q4 2021 | $5,843,000 | +113.1% | 624,300 | +527.4% | 0.01% | +100.0% |
| Q3 2021 | $2,742,000 | – | 99,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $180,006,000 | 15.43% |
| BVF INC/IL | 6,661,503 | $320,285,000 | 12.60% |
| VR Adviser, LLC | 1,536,193 | $73,860,000 | 10.86% |
| Foresite Capital Management IV, LLC | 818,030 | $39,331,000 | 4.27% |
| Cormorant Asset Management, LP | 3,195,544 | $148,169,000 | 3.53% |
| Vivo Capital, LLC | 1,238,575 | $59,551,000 | 2.66% |
| RA Capital Management | 2,150,404 | $103,391,000 | 1.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 696,191 | $33,473,000 | 0.66% |
| Avoro Capital Advisors LLC | 876,986 | $35,646,000 | 0.61% |
| Avidity Partners Management LP | 270,000 | $12,982,000 | 0.42% |